PL4027974T3 - Kompozycja farmaceutyczna zawierająca p-boronofenyloalaninę - Google Patents

Kompozycja farmaceutyczna zawierająca p-boronofenyloalaninę

Info

Publication number
PL4027974T3
PL4027974T3 PL20781115.9T PL20781115T PL4027974T3 PL 4027974 T3 PL4027974 T3 PL 4027974T3 PL 20781115 T PL20781115 T PL 20781115T PL 4027974 T3 PL4027974 T3 PL 4027974T3
Authority
PL
Poland
Prior art keywords
boronophenylalanine
pharmaceutical composition
composition containing
pharmaceutical
composition
Prior art date
Application number
PL20781115.9T
Other languages
English (en)
Inventor
Yoshiya IGUCHI
Yoshimitsu Katakuse
Hideki Nakashima
Original Assignee
Stella Pharma Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stella Pharma Corporation filed Critical Stella Pharma Corporation
Publication of PL4027974T3 publication Critical patent/PL4027974T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1468Containers characterised by specific material properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
PL20781115.9T 2019-09-12 2020-09-11 Kompozycja farmaceutyczna zawierająca p-boronofenyloalaninę PL4027974T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019165835 2019-09-12
PCT/JP2020/034391 WO2021049599A1 (en) 2019-09-12 2020-09-11 Pharmaceutical composition containing p-boronophenylalanine and method for producing same

Publications (1)

Publication Number Publication Date
PL4027974T3 true PL4027974T3 (pl) 2025-04-28

Family

ID=72659849

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20781115.9T PL4027974T3 (pl) 2019-09-12 2020-09-11 Kompozycja farmaceutyczna zawierająca p-boronofenyloalaninę

Country Status (12)

Country Link
US (1) US20220354875A1 (pl)
EP (2) EP4520336A3 (pl)
JP (1) JP7519108B2 (pl)
KR (1) KR20220061953A (pl)
CN (1) CN114144186A (pl)
AR (1) AR119948A1 (pl)
AU (1) AU2020345336B2 (pl)
CA (1) CA3151664A1 (pl)
ES (1) ES3015102T3 (pl)
PL (1) PL4027974T3 (pl)
TW (1) TWI860402B (pl)
WO (1) WO2021049599A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115444857B (zh) * 2022-08-30 2023-08-01 安徽丰原药业股份有限公司 一种氰化物解毒剂注射液的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8712430D0 (en) * 1987-05-27 1987-07-01 Procter & Gamble Liquid detergent
US5157149A (en) 1991-06-04 1992-10-20 The United States Of America As Represented By The United States Department Of Energy Enantioselective synthesis of L-(-)-4- boronophenylalanine (L-BPA)
US5935944A (en) 1993-09-10 1999-08-10 Neutron Technology Corporation Formulation for I.V. administration of the boron delivery drug, boronophenylalanine (BPA)
SE9601348D0 (sv) * 1996-04-10 1996-04-10 Pharmacia Ab Improved containers for parenteral fluids
JP2979139B2 (ja) 1998-03-11 1999-11-15 東北大学長 L−パラボロノフェニルアラニンの製造方法
JP2000212185A (ja) 1999-01-14 2000-08-02 Ajinomoto Co Inc パラボロノフェニルアラニン誘導体の製造方法
WO2007046411A1 (ja) * 2005-10-19 2007-04-26 Dainippon Sumitomo Pharma Co., Ltd. イソキサゾール化合物の安定化方法
JP5150084B2 (ja) * 2006-10-17 2013-02-20 日本ケミカルリサーチ株式会社 高水溶性p−ボロノフェニルアラニン含有組成物
DK2080501T3 (en) * 2006-10-27 2015-08-03 Otsuka Pharma Co Ltd Package containing drug solution with reduced dissolved oxygen content
JP5345771B2 (ja) 2007-08-27 2013-11-20 公立大学法人大阪府立大学 p−ボロノフェニルアラニンとソルビトールとを含有する液状組成物
JP2013173804A (ja) * 2013-06-14 2013-09-05 Osaka Prefecture Univ p−ボロノフェニルアラニンとソルビトールとを含有する液状組成物
CN103690470A (zh) * 2013-07-09 2014-04-02 四川科伦药业股份有限公司 一种医用塑料包装液体制剂及其灭菌方法和制备方法

Also Published As

Publication number Publication date
EP4027974A1 (en) 2022-07-20
ES3015102T3 (en) 2025-04-29
TWI860402B (zh) 2024-11-01
EP4027974B1 (en) 2025-02-26
KR20220061953A (ko) 2022-05-13
CN114144186A (zh) 2022-03-04
US20220354875A1 (en) 2022-11-10
JP2022547764A (ja) 2022-11-16
EP4027974C0 (en) 2025-02-26
AU2020345336B2 (en) 2025-12-11
TW202123946A (zh) 2021-07-01
WO2021049599A1 (en) 2021-03-18
CA3151664A1 (en) 2021-03-18
EP4520336A2 (en) 2025-03-12
AU2020345336A1 (en) 2022-01-27
EP4520336A3 (en) 2025-05-07
JP7519108B2 (ja) 2024-07-19
AR119948A1 (es) 2022-01-19

Similar Documents

Publication Publication Date Title
GB202019241D0 (en) Pharmaceutical composition
GB201911517D0 (en) Pharmaceutical composition
GB201807053D0 (en) Pharmaceutical composition
IL290469A (en) Oral pharmaceutical preparation
ZA202006541B (en) Pharmaceutical composition comprising brexpiprazole
HUE064916T2 (hu) Gyógyászati készítmény
IL285728A (en) Pharmaceutical composition
PL3949952T3 (pl) Kompozycja farmaceutyczna
SG11202103374TA (en) Pharmaceutical composition
PL4027974T3 (pl) Kompozycja farmaceutyczna zawierająca p-boronofenyloalaninę
GB202208464D0 (en) Pharmaceutical composition
GB202104224D0 (en) Pharmaceutical composition
GB202018068D0 (en) Pharmaceutical composition
GB202010340D0 (en) Pharmaceutical composition
GB201912686D0 (en) Pharmaceutical composition
GB201908003D0 (en) Pharmaceutical composition
IL286162A (en) Pharmaceutical preparations containing anti-lingo-1 antibodies
GB202109271D0 (en) Pharmaceutical composition
GB202108387D0 (en) Pharmaceutical composition
GB202107518D0 (en) Pharmaceutical composition
GB202105858D0 (en) Pharmaceutical composition
GB202105462D0 (en) Pharmaceutical composition
GB202105049D0 (en) Pharmaceutical composition
GB202105047D0 (en) Pharmaceutical composition
GB202102100D0 (en) Pharmaceutical composition